Winston & Strawn Represents PreventionGenetics

Winston & Strawn represented PreventionGenetics, a CLIA-certified and CAP-accredited clinical DNA testing laboratory providing more than 5,000 predefined genetic tests for nearly all clinically relevant genes, additional custom panels, and comprehensive germline whole exome and whole genome sequencing tests, in its sale to Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests.

PreventionGenetics' comprehensive genetic testing portfolio complements Exact Sciences' advanced cancer tests, enabling disease prevention and earlier cancer detection to benefit patients across decades of life. PreventionGenetics’ foundational laboratory and skilled team with experience in sequencing, informatics, and genetic counseling will support Exact Science’s entrance into hereditary cancer testing.

Press Release: https://www.prnewswire.com/news-releases/exact-sciences-acquires-preventiongenetics-to-accelerate-availability-of-hereditary-cancer-testing-for-more-patients-301456755.html

Winston Team:

Kyle Gann, Lead Partner, Chicago

Matt Bergmann, Lead Partner, Chicago

Olga Loy, Partner, Chicago

Jeff Shuman, Partner, Chicago

Eric Knickrehm, Of Counsel, Washington, DC

Amy Inagaki, Associate, Los Angeles

Rachel Wilson, Associate, Chicago